{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:09:02Z","timestamp":1794863342848,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High flow nasal cannula (HFNC) is increasingly being used to support patients with acute respiratory failure (ARF) and to avoid need for intubation. However, almost one third of the patients do not respond and require escalation of respiratory support. Previously, ROX index (SpO<jats:sub>2<\/jats:sub>\/FIO<jats:sub>2<\/jats:sub> [SF] ratio\/respiratory rate) has been validated among pneumonia patients to facilitate early recognition of patients likely to fail HFNC and therefore, benefit from timely interventions. However, it has been postulated that incorporation of PaO<jats:sub>2<\/jats:sub>\/FIO<jats:sub>2<\/jats:sub> (PF) ratio from arterial blood gas (ABG) analysis may better predict the outcome of HFNC compared to indices that utilizes SF ratio. Similarly, heart rate increase after HFNC therapy initiation has been found to be associated with HFNC failure. Therefore, we aimed to compare ROX index with a new modified index to predict HFNC outcomes among ARF patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This single centre 2-year retrospective study included ARF patients of varying etiologies treated with HFNC. The modified index incorporated heart rate and substituted PF ratio for SF ratio in addition to respiratory rate. We named the index POX-HR and calculated Delta POX-HR index as the difference pre- and post-HFNC initiation POX-HR. We also recorded ROX index at the time when post-HFNC initiation ABG was done (\u2018post-HFNC initiation ROX\u2019) and calculated Delta ROX. HFNC success was defined as no need of escalation of respiratory support or discharged to ward within 48\u00a0h of HFNC initiation, or successful wean off HFNC for at least 12\u00a0h. Evaluation was performed using area under the receiver operating characteristic curve (AUROC) and cut-offs assessed for prediction of HFNC outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred eleven patients were initiated on HFNC for ARF, of whom 72 patients (64.9%) had HFNC success. Patients with HFNC failure had significantly lower values for all the indices. At median of 3.33\u00a0h (IQR 1.48\u20137.24\u00a0h), Delta POX-HR demonstrated the best prediction accuracy (AUROC 0.813, 95% CI 0.726\u20130.900). A Delta POX-HR\u2009&gt;\u20090.1 was significantly associated with a lower risk of HFNC failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our proposed modified dynamic index (Delta POX-HR) may facilitate early and accurate prediction of HFNC outcomes compared to ROX index among ARF patients of varied etiologies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-02121-9","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T18:05:48Z","timestamp":1663351548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of ROX index (SpO2\/FIO2 ratio\/respiratory rate) with a modified dynamic index incorporating PaO2\/FIO2 ratio and heart rate to predict high flow nasal cannula outcomes among patients with acute respiratory failure: a single centre retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Amit","family":"Kansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Jun Dan","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Dhanvijay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arbe Tisha Pepito","family":"Siosana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loraine Mae","family":"Padillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Keat","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gulati Kansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheem Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"issue":"4","key":"2121_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4187\/respcare.07663","volume":"65","author":"J Li","year":"2020","unstructured":"Li J, Jing G, Scott JB. Year in Review 2019: High-flow nasal cannula oxygen therapy for adult subjects. Resp Care. 2020;65(4):545\u201357. https:\/\/doi.org\/10.4187\/respcare.07663.","journal-title":"Resp Care"},{"key":"2121_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jcrc.2016.05.022","volume":"35","author":"O Roca","year":"2016","unstructured":"Roca O, Messika J, Caralt B, Garc\u00eda-de-Acilu M, Sztrymf B, Ricard JD, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care. 2016;35:200\u20135. https:\/\/doi.org\/10.1016\/j.jcrc.2016.05.022.","journal-title":"J Crit Care"},{"issue":"11","key":"2121_CR3","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","volume":"199","author":"O Roca","year":"2019","unstructured":"Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hern\u00e1ndez G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199(11):1368\u201376. https:\/\/doi.org\/10.1164\/rccm.201803-0589OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2121_CR4","doi-asserted-by":"publisher","unstructured":"Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185\u201396. https:\/\/doi.org\/10.1056\/NEJMoa1503326","DOI":"10.1056\/NEJMoa1503326"},{"issue":"4","key":"2121_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00134-015-3693-5","volume":"41","author":"BJ Kang","year":"2015","unstructured":"Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015;41(4):623\u201332. https:\/\/doi.org\/10.1007\/s00134-015-3693-5.","journal-title":"Intensive Care Med"},{"issue":"12","key":"2121_CR6","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","volume":"43","author":"E Azoulay","year":"2017","unstructured":"Azoulay E, Pickkers P, Soares M, Perner A, Rello J, Bauer PR, et al. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med. 2017;43(12):1808\u201319. https:\/\/doi.org\/10.1007\/s00134-017-4947-1.","journal-title":"Intensive Care Med"},{"issue":"9","key":"2121_CR7","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.21037\/jtd.2017.08.09","volume":"9","author":"WY Kim","year":"2017","unstructured":"Kim WY, Sung H, Hong SB, Lim CM, Koh Y, Huh JW. Predictors of high flow nasal cannula failure in immunocompromised patients with acute respiratory failure due to non-HIV pneumocystis pneumonia. J Thorac Dis. 2017;9(9):3013\u201322. https:\/\/doi.org\/10.21037\/jtd.2017.08.09.","journal-title":"J Thorac Dis"},{"issue":"6","key":"2121_CR8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4187\/respcare.08631","volume":"66","author":"A Chandel","year":"2021","unstructured":"Chandel A, Patolia S, Brown AW, Collins C, Sahjawani D, Khangoora V, et al. High-flow nasal cannula therapy in COVID-19: using the ROX index to predict success. Respir Care. 2021;66(6):909\u201319. https:\/\/doi.org\/10.4187\/respcare.08631.","journal-title":"Respir Care"},{"key":"2121_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40560-020-00458-z","volume":"8","author":"KJ Goh","year":"2020","unstructured":"Goh KJ, Chai HZ, Ong TH, Sewa DW, Phua GC, Tan QL. Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate. J Intensive Care. 2020;8:41. https:\/\/doi.org\/10.1186\/s40560-020-00458-z.","journal-title":"J Intensive Care"},{"key":"2121_CR10","doi-asserted-by":"publisher","unstructured":"Lemiale V, Dumas G, Demoule A, P\u00e8ne F, Kouatchet A, Bisbal M, et al; The Groupe de Recherche en Reanimation Respiratoire du patient d\u2019Onco-H\u00e9matologie (GRRR-OH). Performance of the ROX index to predict intubation in immunocompromised patients receiving high\u2011flow nasal cannula for acute respiratory failure. [published correction appears in Ann Intensive Care. 2021;11(1):105]. Ann Intensive Care. 2021;11(1):17. https:\/\/doi.org\/10.1186\/s13613-021-00801-z","DOI":"10.1186\/s13613-021-00801-z"},{"issue":"5","key":"2121_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.pulmoe.2021.07.001","volume":"27","author":"ML Vega","year":"2021","unstructured":"Vega ML, Dongilli R, Olaizola G, Colaianni N, Sayat MC, Pisani L, et al. COVID-19 Pneumonia and ROX index: time to set a new threshold for patients admitted outside the ICU. Pulmonology. 2021;27(5):475\u20136. https:\/\/doi.org\/10.1016\/j.pulmoe.2021.07.001.","journal-title":"Pulmonology"},{"issue":"2","key":"2121_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/ALN.0000000000003578","volume":"134","author":"PE Bickler","year":"2021","unstructured":"Bickler PE, Feiner JR, Lipnick MS, McKleroy W. \u201cSilent\u201d presentation of hypoxemia and cardiorespiratory compensation in COVID-19. Anesthesiology. 2021;134(2):262\u20139. https:\/\/doi.org\/10.1097\/ALN.0000000000003578.","journal-title":"Anesthesiology"},{"key":"2121_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/ajplegacy.1947.149.2.277","volume":"149","author":"RD Dripps","year":"1947","unstructured":"Dripps RD, Comroe JH Jr. The effect of the inhalation of high and low oxygen concentrations on respiration, pulse rate, ballistocardiogram and arterial oxygen saturation (oximeter) of normal individuals. Am J Physiol. 1947;149:277\u201391. https:\/\/doi.org\/10.1152\/ajplegacy.1947.149.2.277.","journal-title":"Am J Physiol"},{"issue":"2","key":"2121_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/CCM.0000000000002818","volume":"46","author":"JP Frat","year":"2018","unstructured":"Frat JP, Ragot S, Coudroy R, Constantin JM, Girault C, Prat G, et al. Predictors of intubation in patients with acute hypoxemic respiratory failure treated with a noninvasive oxygenation strategy. Crit Care Med. 2018;46(2):208\u201315. https:\/\/doi.org\/10.1097\/CCM.0000000000002818.","journal-title":"Crit Care Med"},{"issue":"1","key":"2121_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1164\/rccm.201902-0419LE","volume":"200","author":"HMR Karim","year":"2019","unstructured":"Karim HMR, Esquinas AM. Success or failure of high-flow nasal oxygen therapy: the ROX index is good, but a modified ROX index may be better. Am J Respir Crit Care Med. 2019;200(1):116\u20137. https:\/\/doi.org\/10.1164\/rccm.201902-0419LE.","journal-title":"Am J Respir Crit Care Med"},{"key":"2121_CR16","doi-asserted-by":"publisher","unstructured":"Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou PC, et al; NIH\/NHLBI PETAL Network Collaborators. Nonlinear imputation of Pao2\/Fio2 from Spo2\/Fio2 among patients with acute respiratory distress syndrome. Chest. 2016;150(2):307\u201313. https:\/\/doi.org\/10.1016\/j.chest.2016.01.003","DOI":"10.1016\/j.chest.2016.01.003"},{"key":"2121_CR17","doi-asserted-by":"publisher","unstructured":"Brown SM, Duggal A, Hou PC, Tidswell M, Khan A, Exline M, et al; NIH\/NHLBI PETAL Network. Non-linear imputation of PaO2\/FIO2 from SpO2\/FIO2 among mechanically ventilated patients in the intensive care unit: a prospective, observational study. Crit Care Med. 2017;45(8):1317\u201324 https:\/\/doi.org\/10.1097\/CCM.0000000000002514","DOI":"10.1097\/CCM.0000000000002514"},{"issue":"3","key":"2121_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4103\/lungindia.lungindia_106_17","volume":"34","author":"A Madan","year":"2017","unstructured":"Madan A. Correlation between the levels of SpO2 and PaO2. Lung India. 2017;34(3):307\u20138. https:\/\/doi.org\/10.4103\/lungindia.lungindia_106_17.","journal-title":"Lung India"},{"issue":"9","key":"2121_CR19","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4187\/respcare.07403","volume":"65","author":"BK Kim","year":"2020","unstructured":"Kim BK, Kim S, Kim CY, Cha J, Lee YS, Ko Y, et al. Factors associated with failure of high-flow nasal cannula. Respir Care. 2020;65(9):1276\u201384. https:\/\/doi.org\/10.4187\/respcare.07403.","journal-title":"Respir Care"},{"issue":"7","key":"2121_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S2213-2600(22)00096-0","volume":"10","author":"R Coudroy","year":"2022","unstructured":"Coudroy R, Frat J-P, Ehrmann S, P\u00e8ne F, Decav\u00e8le M, Terzi N, et al. High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med. 2022;10(7):641\u20139. https:\/\/doi.org\/10.1016\/S2213-2600(22)00096-0.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"2121_CR21","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1007\/s00134-020-06177-1","volume":"46","author":"N Zucman","year":"2020","unstructured":"Zucman N, Mullaert J, Roux D, Roca O, Ricard JD. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure. Intensive Care Med. 2020;46(10):1924\u20136. https:\/\/doi.org\/10.1007\/s00134-020-06177-1.","journal-title":"Intensive Care Med"},{"issue":"4","key":"2121_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bja\/aex231","volume":"119","author":"C Fuchs","year":"2017","unstructured":"Fuchs C, Wauschkuhn S, Scheer C, Vollmer M, Meissner K, Kuhn S-O, et al. Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days. Br J Anaesth. 2017;119(4):616\u201325. https:\/\/doi.org\/10.1093\/bja\/aex231.","journal-title":"Br J Anaesth"},{"issue":"3","key":"2121_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1164\/rccm.201402-0364OC","volume":"190","author":"SM Maggiore","year":"2014","unstructured":"Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al. Nasal high-flow versus venturi mask oxygen therapy after extubation: effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014;190(3):282\u20138. https:\/\/doi.org\/10.1164\/rccm.201402-0364OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2121_CR24","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1007\/s00134-020-06312-y","volume":"46","author":"B Rochwerg","year":"2020","unstructured":"Rochwerg B, Einav S, Chaudhuri D, et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020;46:2226\u201337. https:\/\/doi.org\/10.1007\/s00134-020-06312-y.","journal-title":"Intensive Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02121-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-02121-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02121-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T18:07:23Z","timestamp":1663351643000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-02121-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-02121-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"1 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study methods were approved by the National Healthcare Group Domain-Specific Review Board (DSRB 2020\/01167). We confirm that all methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki). We confirm that our retrospective data collection didn\u2019t subject the patients to any additional experimental protocols. The National Healthcare Group Domain-Specific Review Board approved the study with a waiver of informed consent due to the non-interventional study design (DSRB 2020\/01167).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}